6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
2m ago	Cognizant's Innovation Network a Fast Track to Enterprise Value
3m ago	Li Bang International Announces Regaining Compliance with Nasdaq Minimum Bid Price Requirement
3m ago	More Than a Discount: Drivers Who Bundle Home and Auto See Fewer Coverage Gaps and Smoother Claims
3m ago	American Water's Suzanne Chiavari Named 2026 AWWA George Warren Fuller Award Recipient
4m ago	Disclosure of transparency notification from BlackRock, Inc.

About

Black Diamond Therapeutics Inc (NASDAQ:BDTX) — investor relations, events, news, and company updates on 6ix.

Latest News

Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual Meeting

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Black Diamond Therapeutics Announces Preliminary Phase 2 Data for Silevertinib in 1L NSCLC and Plans for a Phase 2 Trial of Silevertinib in GBM

Black Diamond Therapeutics to Host Webcast Presentation Highlighting Silevertinib Phase 2 Clinical Trial Results and Program Update

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

Financials

Revenue

$70 M

Market Cap

$143.22 M

P/E Ratio

6.41

EPS

0.39

Community Chat

Ask AI